SKP-Studienzentrum der kardiologischen Praxisgemeinschaft Rankestrasse GmbH

Berlin 6 trials 4 recruiting

6 Registered trials

4 Currently recruiting

Organisation

SKP-Studienzentrum der kardiologischen Praxisgemeinschaft Rankestrasse GmbH

Location

Berlin, Germany

Identifier

ORG-100047217

Address

Rankestrasse 34, Charlottenburg, 10789, Germany

Departments

#3510
2209: SKP Studienzentrum der kardiologischen Praxisgemeinschaft Rankestrasse GmbH
3510
N/A
NA

Clinical trials at this site (6)

Search interface

An open-label extension (OLE) trial to evaluate long-term safety and tolerability of pelacarsen (TQJ230) Recruiting

2024-519870-38-00 Atherosclerotic cardiovascular disease (ASCVD) 5 2026-05-11
Lp(a) lowering study of pelacarsen (TQJ230) with background inclisiran in participants with elevated Lp(a) and established ASCVD Recruiting

2024-516356-18-00 Atherosclerotic cardiovascular disease (ASCVD) 5 2026-02-17
ZENITH: Zilebesiran in Patients with Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk … Recruiting

2025-522960-34-00 Established cardiovascular disease 5 2026-02-09
A study to test whether vicadrostat (BI 690517) in combination with empagliflozin helps people with heart failure. Recruiting

2023-509706-30-00 Heart failure (HF) 5 2024-10-18
A Phase 3 Randomized, Placebo-Controlled Clinical Study to Evaluate the Efficacy and Safety of MK-0616 in Reducing Major Adverse Cardiovascu… Ended

2022-502781-24-01 ASCVD - Atherosclerotic Cardiovascular Disease 5 2024-06-05
A multicenter trial assessing the impact of lipoprotein (a) lowering with pelacarsen (TQJ230) on major cardiovascular events in patients wit… Ended

2023-508292-37-00 Cardiovascular Disease 5 2020-03-06